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REVIEW OF THE LITERATURE 
Introduction: 
The inability of patients with diabetes mellitus to metabolize a 
glucose load and the persistence of plasma glucose elevated above 
normal fasting levels in such patients have formed the basis for the 
oral and intravenous glucose tolerance tests in the diagnoses of diabete 
1 2 3 A 
mellitus. ’ ’ * The abnormal persistence of elevated plasma glucose 
is related to the absolute lack of production of insulin in juvenile-’ 
type diabetics, or the relative inability of the beta cells of the 
pancreas to respond quickly enough with sufficient insulin output 
to metabolize the ingested glucose load in adult-onset diabetes,”* 
That the hormonal abnormalities in diabetes have profound effects on 
amino acid metabolism as well as glucose metabolism has only recently 
become the focus of attention; the common hormonal defect in this 
disease may serve as a model and experimental tool for the understanding 
of the hormonal interrelationships in protein and carbohydrate homeo¬ 
stasis. The present study involves an examination of the in ter ""action 
of glucose and amino acid metabolism in diabetes. To provide back¬ 
ground information, studies on inter-organ amino acid exchange will be 
reviewed in this paper, with particular emphasis on the alterations 
of body metabolism during the absorptive state and the resulting 
6 7 
hormonal and amino acid changes in normal and diabetic man. *’ 
The. Post-absorptive State: 
The free amino acid concentrations in the blood of normal humans 
reflect a delicate balance between uptake by some tissues for protein 
utilize tier, and output by other tissues as a result of protein breakdown 
\ 
2 
and intermediary metabolic processes. The post-absorptive state, which 
is generally defined as the time following 10-14 hour overnight fast, 
involves continuing net transfer of nitrogen and energy substrate 
between organs that maintains constant concentrations of individual 
g 
amino acids that vary little from subject to subject. Much attention 
has been given to muscle and liver as the source and destination, 
respectively, of the circulating amino acids, since muscle accounts 
9 
for over 50 per cent of the total body source of amino acids and 
because the liver contains the enzymes necessary for urea formation and 
for nitrogen disposal. 
Several experiments have demonstrated that there is a continuous 
net amino acid release by peripheral muscle tissue in normal post- 
absorptive man, when arterio-venous amino acid differences are measured 
across the deep tissues of the human forearm, across the leg, 
and across the heart.The pattern of amino acid release shows a 
consistent predominance of alanine and glutamine which account for 50 
] 1 
per cent of total alpha amino nitrogen released in the arm and for 
over 80 per cent of amino acids released bv human mvocardium 
13,14 
This output is accompanied by a small but consistent uptake of serine, 
cystine, and glutamate in peripheral tissues.^ 
Alanine and glutamine predominate in the net uptake of amino acids 
across the splanchnic bed, as measured in humans with arterio-hepatic 
venous differences. When hepatic and extra-hepatic contributions are 
separated out by analysis of arterial-portal venous differences, it 
appears that the gut takes up most of the glutamine, while releasing 




These results In man have been confirmed in fasted rats, showing 
release of alanine, glutamine, and glycine by peripheral tissues, up¬ 
take of glutamine and serine with release of alanine and some glycine 
by extra-hepatic splanchnic tissues, and uptake of alanine by the 
liver,^ In the fasted state, there is a net output of alanine by the 
gut which is matched by a two-fold greater alanine uptake by the liver. 
Eviscerated rats accumulated glutamine at an accelerated rate 
relative to normals, indicating the importance of the gut as a site of 
. _ . _ , , . 17,18,19 In addition, loading the femoral vein 
glutamine cataoolism. 
with glutamine in fasted rats results in a large output of alanine 
and ammonia into the portal circulations, showing evidence of uptake 
of glutamine and release of alanine by the extra-hepatic splanchnic 
20 
tissues. The results support the concept of alanine and glutamine 
as "end products” of amino acid metabolism in peripheral tissues which 
serve as "nitrogen carriers” from organ to organ, with alanine as the 
16* i 7 
final "end product" for uptake into the liver. *' 
The liver was found to be the source of uptake of alanine, glycine, 
serine, threonine, and other glycogenic amino acids. Because alanine 
is the amino acid in the portal circulation with the largest uptake by 
the liver, it appears to be the principal nitrogen-containing pre- 
2 3 
cursor of glucose production in the liver. The rate of gluconeo- 
genesis in the liver is related to the availability of alanine as a 
substrate; the metabolic pathways for gluconeogenesis from alanine do 
not reach saturation until the alanine concentration reaches 20 to 30 
22 14 
times physiological levels. Incorporation of C labelled alanine 




a period of several days. * In the post-absorptive state, the 
25 
liver accounts for almost 100 per cent of glucose production, 
20 to 30 per cent of the glucose is produced in the liver by gluconec- 
genesis from uptake of circulating precursors, while hepatic glyco- 
genolysis accounts for the remaining 70 to 80 per cent. According 
7 
to Felig alanine uptake contributes to 5 to 12 per cent of the total 
hepatic glucose output, while lactate serves as the substrate for 10 
to 15 per cent of the glucose and the remaining glycogenic amino 
acids contribute an additional 5 per cent of the total glucose pro¬ 
duction. Since alanine serves as the substrate for 20 per cent to 
30 per cent of the total liver gluconeogenesis in the post-absorptive 
state, its uptake by the liver accounts for a progressively greater 
share of the total glucose output as fasting continues beyond 24 
21 
hours, at which point hepatic stores of glycogen have been ex¬ 
hausted . ^ 
The branched chain amino acids leucine, isoleucine and valine are 
among the few amino acids which have no uptake by the liver or splanch- 
13 21 
nic bed in the post-absorptive state. * ' These amino acids are re¬ 
leased in small amounts from peripheral muscle as measured by arterio- 
13 
venous differences in the post-absorptive state. Blanched chain 
amino acid uptake in the brain is greater than that of other amino 
acids, and valine appears to be taken up particularly well, as measured 
26 27 
by arterial-jugular venous differences in man* and in mice. The 
brain is, therefore, an important site of branched chain amino acid 
utilization in the post-absorptive state. 
Arterio-venous studies across the kidney show that it takes up 




into the circulation. J The kidney is the major source of serine re¬ 
lease into the circulation, while its uptake of glutamine and output 
20 
of alanine is small in comparison with the gut. 
Alanine accounts for no more than 7 to 10 per cent of the con- 
, , .6,29,30,48 . 
stituent amino acids in muscle protein and yet it makes up 
30 per cent of the net muscle output of amino acids. It Increases in 
great quantity in exercising man, disproportionately to the rate of 
13 
protein catabolism that might occui' in this state. This led Felig, 
31 13 32 
et al, * and Mallette, et al, to propose a "glucose-alanine" 
cycle in which pyruvate derived from carbohydrate is converted to 
alanine by transamination in peripheral muscie. The alanine released 
by muscle is transported to the liver, where its carbon skeleton 
is converted to glucose, which travels from the liver back to peripheral 
muscle. This concept has been extensively supported by in vitro and 
in vivo experiments which have already been reviewed,^ and it has been 
calculated that the glucose-alanine cycle recycles carbon skeletons 
at about one half the rate of the Cori lactate cycle, which it parallels. 
The functioning of the glucose-alanine cycle requires that periph¬ 
eral muscle be supplied with a nitrogen-containing substrate for the 
transamination of pyruvate to alanine. The branched chain amino 
7 13 
acids have been suggested as this nitrogen source’’ because they 
appear to be the principal amino acids that are specifically taken 
up and metabolized by extra-hepatic tissues as opposed to the liver. 
In the post-absorptive state, however, no consistent uptake of the 
7 13 
branched chain amine acids is seen * ' and peripheral muscle exists 
in negative alpha amino nitrogen balance.'’^ Alpha amino nitrogen 
33 
repletion in muscle must, therefore, occur during the absorptive state, 

6 
as opposed to the situation in the brain, where there is continuous 
26 27 
branched chain amino acid uptake even during fasting. * 
The Absorptive State: 
Protein Ingestion: Studies on ingestion of protein in humans 
and animals have helped elucidate the mechanism of nitorgen repletion 
in peripheral muscle. Over 60 years ago, vanSlyke and Meyer demon¬ 
strated in dogs that protein ingestion results in elevation of free 
34 
amino acid levels in the blood. Experiments by Frame on protein 
ingestion in humans identified the specific patterns of amino acid 
35 
concentrations in plasma after protein ingestion. Normal subjects 
ingested a mixture of raw eggs and milk containing approximately 60 
gm of protein, and the venous plasma amino acid concentrations were 
determined at hourly intervals for eight hours after the meal. The 
pattern of amino acid rise in venous plasma did not parallel the rela¬ 
tive amino acid concentrations of the food. The branched chain amino 
acids leucine, isoleucine and valine rose in concentration the most 
markedly of all the amino acids, increasing to two arid one half times 
the fasting values and remaining elevated above normal at eight hours 
after the meal. Methionine, phenylalanine, serine, threonine, tyrosin 
and glutamic acid increased more moderately than the branched chain 
amino acids. Alanine and glycine were characterized by a small rise 
followed by a fall in plasma concentrations to below the fasting level 
The "eggnog” mixture consumed by the patients contained a not in¬ 
considerable amount of carbohydrate and lipid. Other experiments with 




branched chain amino acids relative to other amino acids 
Wahren, Felig and Hagenfeldt have recently presented important 
data on the exchange of amino acids across the splanchnic bed and periph- 
33 
eral leg muscle in humans after a protein meal. Both normal and 
diabetic subjects consumed lean beef, three grams per kilogram of 
body weight. In normals, there was a large net splanchnic release of 
branched chain amino acids, accounting for more than half of the total 
splanchnic amino acid output. The increments in the arterial concen¬ 
trations of the branched chain amino acids were the largest of the 
amino acids, (100% to 200%), with isoleucine, leucine and valine 
accounting for more than half of the total amino acid uptake across 
the leg. Following the protein meal, the net output of amino acids 
across the leg in the basal state switched to a net uptake in which 
the branched chain amino acids predominated. The ongoing alanine and 
glutamine output by the leg continued to be matched by a net uptake 
by the splanchnic bed following the protein meal, although the rate of 
output of alanine and glutamine transiently decreased at 30 and 60 
minutes following the meal. 
These results closely correlated with experiments of amino acid 
37 38 39 
balance following protein ingestion in dogs, rats, and sheep.' 
In each of the experiments, alanine was the predominant amino acid 
released by the gut after protein ingestion, and liver uptake of amino 
matched gut output in all cases, with the exception of the branched 
chain amino acids. As in the human studies, hepatic uptake of the 
branched chain amino acids was small and resulted in selective splanch¬ 
nic escape of isoleucine, leucine and valine into the systemic circula- 

8 
tion, accounting for the disproportionate rise of these aroi.no acids 
in peripheral blood. Protein ingestion, therefore, compensates for 
the ongoing negative nitrogen balance in peripheral muscle by supply- 
ing branched chain amino acids for peripheral uptake. Branched chain 
amino acids are selectively catabolized in muscle, as shown by in vitro 
40,41 
rat diaphragm experiments; the addition of branched chain amino 
14 3 4 
acids in this system increases the production of C alanine from C 
glucose. Alanine production thus does not necessarily reflect 
protein degradation in muscle, but may be related to catabolism of 
13 30 
ingested branched chain amino acids. 
Glucose Ingestion: The ingestion of glucose in normal man re¬ 
sults in an increase in arterial concentrations of alanine, pyruvate 
and lactate, along with a fall in the levels of the branched chain 
42 
amino acids and methionine, tyrosine, phenylalanine and serine. 
Measurement of splanchnic exchange showed a significant (75 per cent) 
fall in the splanchnic uptake of alanine after the oral glucose in¬ 
gestion, with no significant change in splanchnic exchange of the other 
amino acids. This suggested that the effect of oral glucose in 
causing an increase in alanine was a splanchnic, (probably hepatic), 
rather than a peripheral one, which was related to the accompanying 
insulin rise. It had already been demonstratea that peripheral output 
of alanine was unaffected by physiological increments in arterial insulin 
1? 
concentration. It is important to note that there is a significant 
portal to peripheral gradient of insulin and glucose following an 
43 44 
oral glucose tolerance test. Since only fifteen percent of the 
100 grams of glucose ingested is actually permitted to reach the 
peripheral circulation for insulin-dependent utilization within three 

9 
hours after a glucose tolerance test, there is a probable net uptake 
of glucose in the liver accompanying the lowering of the uptake of the 
42 
gluconeogenic precursors alanine, lactate and pyruvate. The lowering 
of the branched chain amino acids in response to glucose ingestion is 
presumed to be an effect of the greater insulin levels in increasing 
45 46 47 
peripheral uptake and utilization of these amino acids. ’ * 
Starvetion and protein deprivation: 
Starvation lasting for several days in normal man initially produces 
a marked rise in branched chain amino acids and a lowering of plasma 
alanine in venous blood, accompanied by a fall in insulin and a rise 
21,48 
in glucagon.' The alanine fall may be caused by the initial in¬ 
crease in hepatic gluconeogenesis to preserve glucose output in the 
face of diminishing glycogen reserves. 
6,48 
As starvation progresses, 
increasing ketone levels may contribute to the lowering of alanine 
49 
release from muscle. The cause of the rise in branched chain 
amino acids is unknown; the hypoinsulinemia of starvation may be a 
factor, but peripheral muscle and liver have been shown not to contribute 
to the rise in the branched chain amino acids in this condition, and 
another source of output or diminished uptake of these amino acids 
must be discovered.^ When normal subjects are fed a non-protein diet 
that is isocaloric with a normal diet, there is a significant rise 
in the concentration of alanine when compared to both the fasting and 
a 
normal fed state, indicating that^protein-free diet may shut off 
gluconeogenesis in the liver, thereby decreasing hepatic uptake and 
48 
catabolism of alanine. Protein deprivation also was shown to blunt 
the rise of plasma valine, in response to starvation, while having r.o 
48 
significant effect on isoleucine and valine levels. The rise in 

10 
insulin in response to ongoing carbohydrate and lipid intake probably 
causes decreased branched chain amino acid uptake at peripheral sites 
and participates in shutting off gluconecgenesis in the liver. In 
addition, the feeding of carbohydrate and lipid may ameliorate the 
ketosis of starvation, which would lead to increased peripheral 
catabolism and release of alanine from muscle. 
Diabetes Mellltus: 
The hormonal changes of diabetes involve a reduction in insulin 
50 
levels and a relative or absolute increase in the levels of glucagon.' 
6 
In this way, it resembles the early phase of starvation. Both ketotic 
52 
and non-ketotic diabetics have elevated fasting levels of the 
branched chain amino acids and reduced levels of alanine. Splanchnic 
uptakes of alanine, lactate, and pyruvate are increased by 50 to 100 
per cent, indicating a greater contribution of gluconeogenic precursors 
52 
to hepatic glucose output. There is a greater fractional extrac¬ 
tion of alanine in that alanine levels are lower to begin with, sug¬ 
gesting that the increased gluconeogenesis seen in diabetes is not 
secondary to the availability of circulating metabolic precursors, 
but is a primary defect in hormonal regulation of hepatic metabolism. 
In response to a protein meal, diabetics were found to have a rise 
in the levels of the branched chain amino acids in arterial blood which 
was significantly greater than normal levels of the same amino acids. 
The splanchnic exchange of amino acids in diabetics and controls was 
similar, and peripheral output of alanine, as measured across the 
33 
leg, was not changed after protein ingestion. Leg uptake cf 

11 
branched chain amino acids in normals and diabetics increased similarly 
until 90 minutes after the protein meal. From 90 to 180 minutes, the 
normals continued to have a net uptake of branched chain amino acids 
significantly greater than in the basal state, while the diabetics 
had no significant change from the basal state in peripheral amino 
33 
acid flux. The failure of peripheral muscle to take up branched 
chain amino acids from the circulation contributes to the abnormal 
elevation of these amino acids in the blood, establishing a defect 
in amino acid tolerance in diabetes that is caused by insufficient 
circulating insulin to metabolize the protein load. 
While normal subjects responded to protein ingestion with a 
transient fall in output of alanine from peripheral muscle, there was 
no such decline in diabetics. Arterial alanine levels were consistently 
lower in the diabetic population after a protein meal than in the normal 
subjects, probably reflecting the greater fractional 
extraction of alanine by the liver for ongoing gluconeogenesis. In 
fact, the diabetics responded to protein with a rise in splanchnic 
glucose output that reached three times the basal output while normal 
subjects transiently lowered splanchnic glucose output and returned to 
33 




This experiment will examine the effect of oral glucose in¬ 
gestion on the hormonal and amino acid response to protein in¬ 
gestion. Previous studies have elucidated the role of protein 
ingestion in providing branched chain amino acids for nitrogen 
repletion in muscle. The importance of insulin in promoting 
amino acid uptake and protein anabolism in muscle is well estab¬ 
lished. The increased plasma level of branched chain amino 
acids after protein ingestion in diabetes is thought to be due to 
decreased uptake by muscle, probably caused by insulin lack 
relative to normals. It would, therefore, be useful to know 
whether the added impact of a glucose load on protein ingestion, 
with its concomitant insulin requirements, might accentuate both 
the peripheral and hepatic effects of insulin lack when the 
response of diabetic and normal individuals are compared. 

13 
MATERIALS AND METHODS 
Subj ccts: 
The subjects for the experiments were healthy non—obese volun¬ 
teers and non-obese insulin-dependent diabetic patients. Seven 
diabetic patients and nine normal volunteers ingested glucose 
plus protein. Table I presents the age, body dimensions, sex, the 
number of years since diagnosis of diabetes, the daily insulin dose, 
and the fasting venous plasma glucose of each of the individual 
subjects in the two groups. Body weights are expressed as percent¬ 
ages of the desirable body weights of men and women of given height 
5 
and body frame as prepared by the Metropolitan Life Insurance Comapny. 
The average age of the diabetics for the glucose plus protein ingestion 
was 33 years as opposed to an average age of 26 years for normal 
controls. The body weights of the diabetics averaged 106 per cent 
of the mean desirable value as opposed to 98 per cent in the normal 
volunteers. 
Six diabetic patients and six normal control subjects partici¬ 
pated in the experiment in which protein without glucose was ingested. 
Data on these individual subjects is presented in Table II. The 
average ages of diabetic and normals were 31 and 26 years, respective¬ 
ly. Both the diabetics and normal subjects in this experiment averaged 
103 per cent of the mean desirable body v*eights for their individual 
sex, height, and body frame. 
All of the subjects participating in the study were in good health 
except for the specific problem of diabetes. None of the subjects 
were on any specific weight-losing or weight-gaining diets. None of 




Clinical Data for Diabetic Patients and Healthy Subjects 
Glucose and Protein Ingestion 
Fasting 
















yrs cm kg % vrs III ymol/liter 
Piabet ics 
U.P. 49 M 170 84 117 13 15 3.4 
J.P. 28 M 180 83 105 8 20 7.6 
F.P. 24 F 160 59 100 13 60 12.4 
J.B. 24 M 178 71 99 2 16 5.1 
H.F. 53 M 176 95 119 8 36 7.1 
L.K. 32 F 156 48 99 3 16 14.9 







R.G. 23 M 175 62 go - -■ ** f j r .'J 
J.D. 31 M 175 64 92 - - 4.5 
J.O. 24 M 180 81 109 - - 4,4 
D.S . 21 M 173 64 oo ~ - 4. ] 
D. B. 29 M 180 55 79 - - 4.2 
W.S. 29 M 175 77 110 - -- 4.6 
S.G. 24 F 173 65 102 - - 4.2 
L.H. 29 F 153 58 116 - - 4.8 




Clinical Data for Diabetic Patients and Healthy Subjects 
Protein Ingestion 

















yrs cm kg /o yrs IU ymol/lite 
Diabetics 
J.S. 25 M 170 67 103 17 40+8 CZI 18.3 
L.K. 32 F 156 48 99 3 16 14.9 
H. F. 53 M 176 94 119 8 36 6.2 
L.S. 21 F 163 63 113 8 42 12.8 
J.P. 28 M ISO 83 105 8 20 13.8 
C.F. 26 M 170 58 92 4 28 11.4 
Cent rols 
W.S. 29 M 17 5 77 110 - - 4.7 
J.O. 24 M ISO 81' 100 - - A . 8 
M.J. 23 F 163 49 88 - - 4.3 
L.H. 2D F 153 58 116 - - 4.2 
J.P. 24 y 178 80 111 -- - 4.4 
G.R. 24 M 175 68 98 4.4 
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with diabetes. The diabetics were in good nutritional balance and 
ingested a weight-maintaining diet made up of approximately 40 per 
cent carbohydrate and 25-35 per cent each of protein and fat. All of 
the diabetics received daily insulin injections for their disease, 
and none had any periods of weight loss or known episodes of hypo¬ 
glycemia during the year preceding the study. None of the subjects 
had any evidence of clinical history of peptic ulcer disease, mal¬ 
absorption, or any other recent gastrointestinal disorder. There 
was no history or evidence of liver disease, and none of the subjects 
were known to be ethanol abusers. None of the female participants in 
the study were users of oral contraceptives and no drugs or hormones 
other than insulin were being taken by the subjects on a regular 
basis. No drugs of any sort were taken 24 hours prior to and during 
the experiment. One of the diabetic patients (E.P.) had some evidence 
of necrobiosis diabeticorum on her feet, which another (J.S.) had 
diabetic retinopathy in one eye. None of the other patients had any 
evidence of peripheral vascular disease. All of the subjects were being 
followed medically on a regular basis by physicians at Yale or in the 
New Haven Community. 
The studies were carried out in the outpatient unit of the Clinical 
Research Center of the Yale-New Fa\en Hospital. Prior approval for 
implementation of the experiment was obtained from the. Yale Human 
Investigation Committee. The nature, purpose, and possible risks in 
the study were carefully explained to all patients and control sub¬ 




The subjects in each of the experimental groups underwent an 
overnight fast of 10 to 12 hours prior to the start of the experi¬ 
ment. Insulin was withheld for 24 hours prior to the study. Each 
subject was placed in a recumbent position for the duration of the ex¬ 
periment, and a size 18 Jeico catheter was inserted percutaneously 
for the purpose of drawing blood samples. Patency of the catheter 
was maintained by intermittent flushing with 0.9 per cent saline. No 
subject received more than a 400 cc intravenous load of saline. Heparin 
was not employed in the experiment. 
Three blood samples were drawn at ten minute intervals in the 
half hour prior to the start of the meal in order to obtain base¬ 
line fasting levels of glucose, amino acids, glucagon, and insulin. 
At time zero, each subject started ingesting a protein meal consisting 
of lean boiled beef (raw composition: 22 per cent protein, less than 
5 per cent fat) administered in a dose of 3 g (cooked weight) per kg 
of body weight. Those subjects given glucose along with the protein 
meal simultaneously consumed 100 grams of glucose dissolved in 10 
ounces of lemon flavored water. All subjects consumed their required 
meals within a time period of 20 minutes with the exception of S.G., 
who finished the whole meal in 40 minutes and J.D. who took 45 minutes 
to consume 95 grams of glucose and 75 per cent of the protein load. 
Samples were drawn at 15 minute intervals for a period of three 
hours after the start of the meal. A total of not more than 180 cc 
of blood was drawn during the course of the experiment. Diabetics 
received 50 to 67 per cent of their usual dose of insulin at the 
conclusion of the study and were instructed to have a small bedtime 
snack on the evening following the study. None of the subjects had 

18 
any discomfort or adverse effects from participation in the study 
other than abdominal fullness and aesthetic disapproval of the cuisine. 
Analytical Methods: 
Glucose was analyzed in whole blood using the glucose oxidase 
54 
reaction. Individual amino acids were measured in plasma by the 
automated ion-exchange chromatographic technique. Heparinized 
samples of plasma were deproteinized with sulfasalicylic acid. Due 
to the breakdown of glutamine to glutamate at room temperature 
with this technique, the values for the glutamate and glutamine/ 
asparagine peak are not accurate and, therefore, not reported. The 
basic amino acids vere not measured in these samples. Insulin was 
5 6 
measured by the radioimmunoassay method of Yalow and Berson as 
modified by Herbert, et al. Plasma glucagon was analyzed by radio- 
58 
immunoassay using Unger antibody 30 K. 
The data in the text, tables and figures are given as mean ±SE. 
Standard statistical methods' were employed, including use of the student 





Whole blood concentrations of glucose are presented in Table III 
Basal glucose concentrations in the diabetic groups were two to 
three times those of the normal controls (p<0.005 for glucose protein 
ingestion). After the ingestion of glucose plus protein, glucose 
levels in the diabetics rose significantly above basal levels at 
15 minutes (p<0.05) and remained elevated throughout the study 
period of three hours (p<0,005), reaching twice the basal concen¬ 
tration. In contrast, as seen on Figure 1, the controls had a 
small rise in blood glucose during the first hour after the meal 
(p<0.025), with glucose falling to basal levels thereafter. The 
glucose response to protein ingestion in seen on Figure 2. In 
diabetics, venous blood glucose rose at 90 minutes 
following the meal and steadily thereafter (p<0.05-0.025) so that 
at 180 minutes it was 19 per cent above the basal level. The 
healthy subjects had an approximately nine per cent fall in blood 
glucose at 60 minutes (p<0.0025) and 90 minutes (p<0.00125), 
with glucose the same as basal levels at all other times. The 
glucose responses in normal subjects to protein ingestion, glucose 
64 
plus protein ingestion, and a standard glucose tolerance test' 
are compared in Figure 3. There is little change in blood glucose 
in response to a protein meal in normals. When protein is added 
to a glucose tolerance test, the blood glucose response in normals 
is not dissimilar to the response to ingestion of glucose alone, 





BLOOD GLUCOSE LEVELS 
GLUCOSE+PROTEIN INGESTION 
FIGURE 1. Blood glucose levels for three hours after ingestion 
of glucose plus protein in diabetic and normal groups. Points 
illustrated for this and all other figures are means of experimental 
groups with bars indicating standard errors. Blood glucose 
values for normals and diabetics were statistically different 
over the total time period (p<0.01 -0.0005). 
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BLOOD GLUCOSE LEVELS 
PROTEIN INGESTION 
MINUTES AFTER INGESTION 
FIGURE 2. Blood glucose levels after ingestion of protein in 
diabetics and normals. Values of glucose for diabetic and 
normal groups were statistically different over the entire 
time period (p<0.001-0.0005). 
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BLOOD GLUCOSE LEVELS 
NORMALS 
FIGURE 3. A comparison of blood glucose levels in normal subjects 
after ingestion of glucose plus protein (solid line), protein alone 
(small dotted line), and glucose alone (large dotted line). 
P values listed at 60 and 90 minutes refer to the statistically 
significant lowering of glucose after ingestion of protein alone. 
P value at 150 minutes refers to a statistically significant difference 
between the group ingesting glucose plus protein and the group 




The addition of glucose to a protein meal greatly enhances the 
insulin response in normal subjects (Table III). Plasma insulin 
levels rose quickly to a peak of seven and one half times the basal 
level at 45 minutes, remaining significantly elevated throughout the 
three hour postprandial period (p<0.025-0.001). In contrast, after 
the ingestion of protein alone, insulin levels in normals rose 
significantly only at 60 minutes (p<0.025), 90 minutes (p<0.0i) 
and 120 minutes (p<0.025), reaching a peak of two times the basal, 
level. As illustrated in Figure 4, the insulin response to the 
glucose plus protein meal in this experiment was not significantly 
different from the insulin response to a standard glucose tolerance 
test. Insulin levels could not be measured in diabetics because 
of the presence of circulating antibody to insulin in the blood of 
insulin-dependent diabetics.^ 
Glucagon: 
There was no significant difference in the basal levels of 
glucagoii between diabetics and controls (Table III and Figure 5) . 
After the ingestion of glucose plus protein, glucagon levels in 
diabetics showed a net rise at 90 minutes and thereafter (p<0.05- 
0.025) despite the ongoing hyperglycemia. Normal subjects had a 
25 per cent fall in plasma glucagon at 30 through 60 minutes after 
a glucose-protein meal (p<0.Q5), returning to basal levels after¬ 
ward. Both diabetic and normal subjects shewed two to threefold 
rises in glucagon concentrations in response to a protein meal over 

PLASMA INSULIN LEVELS 
NORMALS 
25 
FIGURE 4. Plasma Insulin values in normals after glucose plus 








PLASMA GLUCAGON LEVELS 
PROTEIN AND GLUCOSE + PROTEIN INGESTION 
FIGURE 5. Levels of glucagon in diabetics and normals after 
ingestion of glucose plus protein (solid lines), and protein 
alone (dotted lines). 
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the three hour postprandial period. The levels of glucagon for both 
the diabetics and normals in this group were not statistically 
different from each other, despite the fact that the diabetics had 
an ongoing, increasing hyperglycemia relative to the normals. 
Amino Acids: 
The basal and postprandial levels of the amino acids of the 
diabetics and normals in both experimental groups are shown in 
Tables IVa and IVb. Basal levels of valine in the diabetics were 
20 per cent greater than in normals (p<0.01). Lower basal levels 
of threonine, methionine and taurine were seen in the diabetics 
(p<0.05). The mean basal levels of the amino acids in diabetics 
ingesting protein were not statistically different from the mean 
basal levels in diabetics ingesting glucose plus protein: the same 
was true for the two groups of normal controls. The mean values of 
leucine and isoleucine tended to be greater in diabetics, while those 
33 53 53 
of alanine tended to be lower as in previous studies, * ’ but 
these changes did not achieve statistical significance. 
In order to compare more effectively the. changes in amino 
acid concentration in each of the four experimental groups, the 
means of the incremental changes from baseline of the amino acids 
of each experimental subjects were calculated, and they are presented 
on Tables Va and Vb. It is evident that the addition of glucose to 
a protein meal blunts or diminishes the rise of most of the amino 
acids in response to a protein meal. The incremental rise in the 
levels cf the individual branched chain amino acids in each experi¬ 
mental group exceeds the rise of each of the other amino acids, 




CONCENTRATIONS OF AMINO ACIDS IN VENOUS PLASMA IN THE BASAL 
STATE AMD AFTER GLUCOSE PLUS PROTEIN INGESTION IN DIABETIC 
PATIENTS (D) AND CONTROL SUBJECTS (C)* 
Basal 30 min 60 min 90 min 120 min 150 min 180 min 
TAU D 32±4 30+3 37l4 32 ±3 34+4 31+3 28+3 + 
C 41±2 37 + 1 § 33+24 36 ±2 <+> 34 + 2 § 35 + 2^ 33 + 14 
TUP D 116+11 120H1 128+12 § 132+9 § 151 + 23 § 155 + 154) 167±164 
r\ 135+10 13718 126 + 8 133+11 151114 160113+ 171+154 
SER D 105±15 110+13 115±14 § 118112^ 130±15+ 134+14+ 1381334 
c 99±5 102.14 93l7 99±7 104 + 7 109+7 | 116±8 § 
GLY D 183±18 183H8 193+15 185+18 205137 204+20| 2.10±19f 
c 201±19 198+20 198120 208116 224122+ 243+224 259126+ 
CIT D 34+5 2914 § 25+4 4) 2314 + 24+3 § 27 + 2 29±] 
C 24 + 3 20+3 t 1514 + 16+3 4> 18+4 18+2 4 19±3 + 
ALA D 295129 301+33 309+30 30o±3S 345138 341+38 349136 
C 297129 324+29+ 331+27^ 363±1°4 3911214) 402128* 42H28 + 
VAL D 245128 245+29 260+28 271133 305+30+ 325+284 3 5 3 ± 3 3 4 
C 218116 221+18 207120 235128 23912.6 262122 § 277±25§ 
1/2CYS D 101110 99+9 10417 95+8 303+8 3.06110 115113 
C 82 + 7 76 + 7 77 + 11 70+8 76+9 78+9 80110 
MET D 26+4 26+3 32 + 3 § 37+4 + 4115 4) & 7 ±4 4 49 + 3 4 
C 2713 27+3 2613 33 ±4 38+6 | 37+4 \ 45±6 § 
TLE D 69+11 7 3111 ^ 85112+ 08+14 + 3.18H24) 133+134 15H174 
c 6214 63+4 58 + 6 67 + 8 8 3131§ °2±12§ 108H44 
LEU D 127+18 137117 § 156+184) 1771224) 207 + 194) 232 + 23.4 260+294 
C 111+9 118+10 110+13 ]24ll7 148+2l| 163±23^ 190+26| 
TYR D 40+s 48+6 50 ±6 5317 59±6 4> 62 + 6 4 6 7 ± 7 4 
r 5314 53+5 4814 51 ±5 57 + 7 62 + 6 65t6 \ 
PHE T) 48+3 51 ±4 55 ±4 4> 59+4 f 66+4 4, 68+4 4 73±4 4 





Data presented as means IS EM in pmol/liter 
Significant difference from corresponding value in the 
Significant difference from corresponding value in the 
Significant difference from corresponding value in the 
Significant difference from corresponding value in the 
basal state p<0.05 
basal state p<0.025 
basal state p<0.01 




CONCENTRATIONS OF AMINO ACIDS IN VENOUS PLASMA IN THE 
BASAL STATE AND AFTER PROTEIN INGESTION IN DIABETIC PATIENTS (D) 
AND CONTROL SUBJECTS (C) 
Basal 30 min 60 min 90 min 120 min 150 min 180 min 
TAU D 29±3 28±3 28±3 3917 3315 2913 2713 
C 38±2 41±2 4112 $ 42+2 5 3912 3812 3511 5 
THR D 92±4 103±6 1371125 17118 4 17218 4 1791134 1761134 
C 142±12 1871164 2101184 2461214 2531224 2451194 2441174 
SER D 107±8 11517 126117 15918 4 14617 4 14418 4 141113+ 
C 113+7 145116 § 1581144 1751134 1711255 1641124 155H44 
CLY D 188+21 187121 2211175 2441174 214112$ 20U14 201114 
C 205±14 2521154 2771194 2971254 3031274 282+224 2591204 
CIT D 26±5 28±3 2414 29±4 2913 3812 3815 $ 
C 29±5 3115 2815 2813 38±4 § 4213 4 4313 + 
ALA D 283+26 286131 326l39| 3491324 3071314 298137 282131 
C 326±30 414126+ 4631204 5071234 5221194 5051154 4681234 
VAL D 252±24 273127 248137+ 444137+ 4701694 4971374 5491264 
C 206±14 272124 3061235 3771264 4331344 4331264 448H94 
1/2 CYS D 83+12 87113 86114 101114 96±17 92115 98112+ 
C 90±10 97110 9218 92110 9617 9416 9419 
MET D 26±1 2314 j ̂ 49±6 4 5815 4 58+3 4 61+7 4 5815 4 
C 31+1 4617 \ 5615 4 ±68±5 4 7919 4 7217 4 7416 4 
ILE D 72 + 7 87110 136119+ 193119+ 2141144 2401204 25418 4 
C 67 + 6 107 + 16 § 1321154 172±17| 197H84 194H44 2001104 
LEU D 136110 1651193 f 2521324 3481304 3761234 4111294 454133+ 
C 114±10 191+323 F 2301274 2951354 3261284 3221214 331+184 
TYR D 51 ±4 5416 70111$ 8819 4 921104 1021154 1001124 
C 50±3 6717 1 3 7816 4 9517 4 1121304 109±9 4 111±7 4 
PHE D 4 7 ±2 53±4 64±6 $ 7214 4 7215 4 7718 4 7716 4 
C 4 7 ±3 6117 ! 5 7115 4 82+3 4 9617 4 86±4 4 85±4 4 
$ Significant dif ference from corresponding v< aloe in the basal state p<0,05 
§ Significant dif ference from corres ponding value in the basal s tate p<0.G2. 
t Significant dif ference from corres ponding v alue in the basal state p<0«01 




MET CHANGE IN PLASMA AMINO ACTD CONCENTRATIONS FROM BASAL 
STATE AFTER GLUCOSE PLUS PROTEIN INGESTION IN DIABETIC (D) 
AND CONTROL SUBJECTS (C) * 
Amino 
Acid 30 min 60 min 00 min 120 min 150 min 180 miri 
TAU D ~2±2 5±A 1+1 1±2 -Til -3±1 
c -Ail -7 ±2 -5±1 -7 ±3 -6i2 -8 ±2 
THR D A ±3 12±A 16±7 35 + 13 3 9 ±8 51 ±9 
C 2±3 -9±6 A±5 16±9 25±8 36±10 
SFR D 5±A 10±A 13±6 2 5 ±8 29±7 33±8 
C 8±6 -7 ±A 2 ±3 5±5 11 ±5 17 ±6 
GLY D 0 + 3 13±7 3±6 22±12 21 ± 11 27 
C -3 ±7 -3±8 -A ±5 23±8 A2±] 1 58 
GIT n -5±2 -9+2 -11 ±3 -10±3 -7±A -A±A 
c -5±2 -11+3 -10±1 -13±1 -9il -5il 
ALA D -1±A 7±8 8 ±15 A 3 ± 2 3 39±27 A7i29 
C 27±8 34+18 66±18 9A±25 105±27 123±37 
VAL D 0±8 1A±9 2 Ail. A 63 + 16 79±o 1 OP, ±141 
C 2±7 -12±12 1 6+19 2 Oil 6 A3±l 6 58 ±23 
CYS u 
c 
MET D A±2 5+2 11±3 15±A 20+3 23±3 
G 0±3 -3+1 3+A 10±5 o±5 17±6 
ILF D 5±2 1 6±A 30+8 /. o+O 6 A ±5 82±10 
C 1+2 -A ±5 5±6 21+10 30+12 A6±1A 
LEU D 10+4 27 + 6 A 8+12 81 ±1A 106±7 13A±17 
C 6+A -2 + 11 37 + 17 50±22 50±22 77 ±25 
TYR D 0±2 1±2 5+A 11 ±4 13±3 1°±A 
C 0+2 -5 ±3 ~2+A 4±5 6±5 13±5 
PHE D 3+2 1±1 11+A 18±A 21±3 25±3 
c A ±3 2±3 A ±3 10±A 12±A 1 7±A 




NET CHANGE IN PLASNA AMINO CONCENTRATIONS FROM BASAL STATF 
AFTER PROTEIN TNGFSTION IN DIABETIC (D) A TIP CONTROL SUBJECTS (C) 
Amino 
Acid 30 min 60 min min 120 min 150 min 180 min 
TAU D -111 -1±2 9±6 4 ±4 0±3 -2±2 
C 2±1 3±1 4±1 1±2 0±2 -4 ±1 
THR D n±7 44 ±14 8 Oil 0 7 9 ± 3 0 87±3 4 83±13 
C 4 6 ±11 68±11 103±12 89 ±18 103±13 102±3 
SER D 9 ±6 3.9 ± 14 5 3 ±6 41 ±7 38±8 35±10 
C 33±n 4 2 ± 7 6 2 ±7 59±19 53 ±6 4 2 ±8 
GLY D -1±6 3 3 ± 13 16±7 26±12 13±10 13±12 
C 47±11 7 2 ± 11 93 ±14 98±20 7 7 ±15 54 ±14 
CIT D -1±2 -3±2 2±3 2±4 9 ±6 12 ±6 
C 3 ±2 -1±3 -2±2 9±3 3 2±2 14 ±4 
ALA D 3 ± 13 43±19 66±9 24±6 3 5 ± 3 5 -1±10 
C 1.02±17 3 3 7 ± 2 3 181 ± 3 2 3 °5±33 ] 7 8 ± 3 3 342±38 
VAL D 2.1 ±11 P5±24 191±29 218±25 245±33 297±19 
c 66±20 ].O0±14 17 3. ± 15 227±30 227±18 242±12 
1/2 CYS D 
C 
net p 7±3 2 2 ±13 33 ±5 3 2 ±4 34 ±7 311 ± 5 
c 3 5±6 25±4 3 7 ±5 49±9 4 2 ±6 42±5 
ILE D 15±7 64 ±17 12111° 3 4 2 ± 14 169±20 18 2 ± 9 
C 3°±3 4 65±11 105±12 129±15 3 26±3 0 132±8 
LEU P 30±14 13 7 ± 2 9 213 ± 2 9 258±19 275±29 33 8±34 
c 77 ±27 13 6±20 3.80±20 23 2±24 208±15 23 7±11 
TYP D 3±1Q 3 °±Q 38±8 4 3 ±7 51 ±3 2 50 ±9 
C 17 ±6 2 7 ± 5 44±6 62±3 0 58±8 63 ±5 
PUP D 6±3 18±5 25±3 2 5 ±4 30±7 30±5 
C 14±6 2 4 ± 4 35±3 4°±8 39±4 38 ±3 




The incremental changes from the basal state are illustrated 
graphically for leucine, isoleucine, and valine, on Figures 6,7 and 8 
The addition of glucose to the protein meal significantly blunted 
the rise in the levels of the branched chain amino acids from 30 
to 180 minutes after the meal in normals (p<0.01-0.0005) and from 
60 to 180 minutes in diabetics (p<0.01-0.0005). After protein in¬ 
gestion, the rise in leucine, isoleucine, and valine were all 
greater in diabetics than normals at 180 minutes (p<0.05-0.005). 
In contrast, after ingestion of glucose plus protein, the diabetics 
had significantly greater increments in leucine concentration than 
normals at 60 minutes (p<0.01), 90 minutes (p<0.05), and 150 minutes 
(p<0.05) with borderline significance at 120 and. 180 minutes 
(p<0.10). Diabetics had greater increases in isoleucine at 60 
minutes through 150 minutes (p<0.05-0.01). There was no significant 
difference in valine between diabetics and normals after ingestion 
of glucose with protein. 
When glucose was added to a protein meal, the total incre¬ 
mental rise of branched chain amino acids in diabetics over the 3 
hour period (24.1313.43 mM*min) was 156% greater than in normals 
(9.4414.85 mM*min, p<0.05) as measured by the mean of the areas 
under the total branched chain amino acid incremental curves for 
each subject. In contrast, after protein ingestion alone, the 
total branched chain amino acid rise ir diabetics (76.6518.90 mM*min) 
was not significantly greater than the total rise for normal 
controls (70.7817.62 mil-in in) . Oral glucose, therefore, accentuates 












PLASMA LEUCINE LEVELS - DIFFERENCE FROM BASELINE 
PROTEIN AND GLUCOSE + PROTEIN INGESTION 
FIGURE 6. Incremental change from basal levels of leucine in diabetics 
and normals during the three hour period after ingestion of glucose 
plus protein (solid lines), and protein alone (broken lines). The 
p values listed above refer to the statistical differences betv/een 










PLASMA ISOLEUCINE LEVELS DIFFERENCE FROM BASELINE 
PROTEIN AND GLUCOSE + PROTEIN INGESTION 
FIGURE 7. Incremental changes from basal levels of isoleucine in 
diabetics and normals after ingestion of glucose plus protein 
(solid lines) and protein alone (broken lines). The p values listed 
above refer to the statistical differences between the diabetic and 











PLASMA VALINE LEVELS - DIFFERENCE FROM BASELINE 
PROTEIN AND GLUCOSE + PROTEIN INGESTION 
FIGURE 8. Incremental changes from basal levels of valine in diabetics 
and normals after ingestion of glucose plus protein (solid lines) 
and protein alone (broken lines). P value above refers to a statistically 
significant difference at 180 minutes between diabetics and normals 
ingesting protein alone. 
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diabetics relative to normals after protein ingestion. 
The pattern of branched chain amino acid rise varied from 
individual subject to subject, but in each person one branched chain 
amino acid "behaved" much like another. Close correlations were 
found when the maximal rise above basal level of one branched 
chain amino acid and another were compared in each subject in an 
experimental group. They are summarized as follows: 
In diabetics ingesting glucose plus protein; 
AILE/ALEU: n=7,r=0.95, p<0.00i 
AVAL/ALEU: n=7, r-0.88, p<0.01 
In diabetics ingesting protein: 
AILE/ALEU: n=6, r-0.90, p<0.01 
AVAL/ALEU: n=6, r=0.60, p<MS 
In normals ingesting glucose plus protein: 
AILE/ALEU: n=9, r=0.99, p<0.001 
AVAL/ALEU: n~9, r-0.73, p<0.02 
In normals ingesting protein: 
AILE/ALEU: n=6, r=0.97, p<0.001 
AVAL/ALEU; n=6,r-0.90, p<0,01 
It, therefore, seemed that a particular metabolic state in an in¬ 
dividual which raised the level of one branched chain amino acid 
would raise another. The maximal rise in leucine, Isoleucine, 
and valine did not correlate however, with either the fasting blood 
glucose or the daily insulin requirement of the diabetes. The 
maximal rise in valine did correlate with the maximal rise, of 
glucose in the glucose-protein ingesting diabetics (n~7, r-0.80, 

37 
p<9.01), but similar correlations between leucine and glucose rise 
(n=7, r=0.69) and isoleucine and glucose (n~7, r--0.54) in the same 
group did not achieve statistical significance. 
Figure 9 shows the alanine changes after ingestion in each of 
the experimental groups. The p values listed on the groups refer 
only to significant differences between diabetics and normals in¬ 
gesting the same type of meal. The rise of alanine in after protein 
alone test was significantly higher in normals throughout the post¬ 
prandial period (p<0.01-0,001). The magnitude of the maximal rise 
in alanine was negatively correlated with the magnitude of the 
valine increment in diabetics (n=7, r-'0.89, p<0.001) and normals 
(n-~9, r=0.68, p<0.05) alter glucose plus protein. The addition 
of glucose to a protein meal appears to significantly lower the rise 
in alanine in normals from 30 to 120 minutes after the meal (p<0.025- 
0.0025) while reducing the disparity in alanine levels between 
normals and diabetics. A very similar pattern is seen for glycine 
in Figure 10. 
Threonine, serine, tyrosine, and phenylalanine are illustrated 
in Figures 11 through 14. Normal and diabetic groups ingesting 
the same type of meal do not differ statistically in the magnitude 
of rise above basal levels for each of the amino acids. The rise 
in normals after protein ingestion tends to be slightly higher than 
in diabetics, but the addition of glucose to the protein meal appears 
to lower the rise in amino acid increments more in normals than in 
diabetics. 

PLASMA ALANINE LEVELS - DIFFERENCE FROM BASELINE 
PROTEIN AND GLUCOSE + PROTEIN INGESTION 
MINUTES AFTER INGESTION 
FIGURE 9. Incremental changes in alanine levels in plasma of diabetics 
and normals after the ingestion of glucose pluse protein (solid lines) 
and protein alone (broken lines). The p values listed above refer 
to statistically significant differences hetvzeen the diabetic and 











PLASMA GLYCINE LEVELS - DIFFERENCE FROM BASELINE 
PROTEIN AND GLUCOSE + PROTEIN INGESTION 
PROTEIN p <0.005 p <0.05 p<0.05 p<0.02 p<0.005 p<0.05 
FIGURE 10. Incremental changes in levels of glycine in plasma of 
diabetics and normals after the ingestion of glucose plus protein 
(solid lines) and protein alone(broken lines). The p values listed 
refer to statistically significant differences in values between 
the diabetic and normal groups ingesting the same type of meal. 
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PLASMA THREONINE LEVELS - DIFFERENCE FROM BASELINE 
PROTEIN AND GLUCOSE + PROTEIN INGESTION 
MINUTES AFTER INGESTION 
FIGURE 11. Incremental changes in plasma threonine in diabetics and 
normal subjects after ingestion of glucose plus protein (solid lines) 
and protein alone (broken lines). The p values listed above refer 
to statistically significant differences between the diabetic and 
normal groups ingesting the same type of meal. 
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PLASMA SERINE LEVELS - DIFFERENCE FROM BASELINE 
PROTEIN AND GLUCOSE + PROTEIN INGESTION 
MINUTES AFTER INGESTION 
FIGURE 12. Incremental changes in plasma serine in diabetics and 
normal subjects after ingestion of glucose plus protein (solid lines) 
and protein alone (broken lines). 
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PLASMA TYROSINE LEVELS - DIFFERENCE FROM BASELINE 
PROTEIN AND GLUCOSE + PROTEIN INGESTION 
MINUTES AFTER INGESTION 
FIGURE 13. Incremental changes in plasma tyrosine in diabetics and 
normal subjects after ingestion of glucose plus protein (solid lines) 
and protein alone (broken lines). 
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PLASMA PHENYLALANINE LEVELS 
DIFFERENCE FROM BASELINE 
PROTEIN AND GLUCOSE + PROTEIN INGESTION 
MINUTES AFTER INGESTION 
| 
l 
FIGURE 14. Incremental changes in plasma phenylalanine in diabetics 
and normal subjects after ingestion of glucose plus protein (solid 
lines) and protein alone (broken lines). The p values listed above 
refer to statistically significant differences between the diabetic 
and normal groups ingesting protein alone at 90 and 120 minutes 




This study examines the effect of oral glucose ingestion and 
its attendant hormonal consequences on the plasma amino acid response 
to protein ingestion in normal postabsorptive man and human diabetics 
33 
A previous study by Wahren, Felig, and Hagenfeldt^ has documented 
the special role cf the branched chain amino acids in replenish¬ 
ment of alpha amino nitrogen in muscle tissue after a protein 
meal. The selective escape of branched chain amino acids from the 
splanchnic bed is accompanied by peripheral uptake and utiliza¬ 
tion of these amino acids by muscle. The insulin deficiency of 
diabetes interferes with the uptake of these amino acids in periph¬ 
eral muscle and results in elevated levels of these amino acids in 
33 
the systemic circulation. 
The findings In protein ingestion in this experiment generally 
correlate with the results of Wahren, et al. The levels of iso¬ 
leucine and leucine were greater in the diabetics at 150-180 
minutes. The failure to observe more persistent hyperaminoacidemia 
in the diabetics may be explained by the fact that the diabetic 
population selected for this experiment was less severely insulin- 
defj.c.ient as reflected by tbs lower mean daily insulin dose than 
those of Wahren, et al.^^ This suggests a greater capacity to 
secrete endogenous insulin in response to protein ingestion than 
in the subjects of the previous experiment. Nevertheless, the presen 
experiment confirmed previous data showing increased levels of 
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glucose, glucagon, and branched chain amino acids and lower levels 
of alanine in the plasma of diabetics in response to protein in¬ 
gestion . 
The changes in the amino acid response to protein ingestion in 
diabetics might best be explained by effects of insulin lack in de¬ 
creasing peripheral uptake of amino acids, combined with the added 
effect of glucagon in stimulating hepatic gluconeogenesis, re¬ 
sulting in increased hepatic uptake of alanine from the circula¬ 
tion. The possibility must be considered that diabetes might in¬ 
fluence the gastrointestinal absorption cf individual amino acids 
and glucose. Rats made diabetic with alloxan or streptozotozin 
developed large increases in their small intestinal mass when com- 
66 
pared with controls, despite losses in total body weight. This 
increase in size was associated with increased hexose transport 
activity per unit weight of Intestinal tissue as measured in vitro 
67 
in everted intestinal sacs and in mucosal scrapings. In vivo 
studies in these rats of gut and splanchnic uptake of nutrients 
were not done, however, and the intestinal hypertrophy might be 
more of a consequence of the marked hyperphagia produced in these 
animals rather than due to the uncontrolled diabetes. Rats made 
hyperphagic due to experimental lesions in the hypothalamus de- 
veloped comparable intestinal hypertrophy. ^ No specific informa¬ 
tion is available to show intestinal hypertrophy or increased 
mucosal transport in well-controlled diabetics with a normal diet. 
Studies of substrate flux across the splanchnic bed in diabetics 
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and normals showed similar levels of splanchnic release of amino 
acids in both groups, and the splanchnic release of glucose seen 
in the diabetics was obviously not due to glucose absorption, be- 
33 
cause no glucose was ingested. The ingestion of glucose plus 
protein, nevertheless, is a slightly different experimental situa¬ 
tion, and although there is no reason to believe that differential 
abilities between diabetics and normals to absorb nutrients may 
play a role in the results of this experiment, it is impossible to 
rule it out. 
The addition of glucose to a protein meal in this experiment 
served to blunt the rise in levels of isoleucine, leucine, valine, 
alanine, threonine, serine, and tyrosine after ingestion of the meal 
in both diabetics and normals. The glucose appeared to decrease 
the incremental rise in normals more than diabetics in the case of 
alanine, threonine, serine, and tyrosine. Glucose ingestion combined 
with protein significantly blunted the rise of glycine and phenylala¬ 
nine, while producing no change that was statistically significant 
in the diabetic subjects. 
The increased insulin response seen with the glucose ingestion 
may provide one explanation for these findings. In normals, the 
addition of glucose to protein raised peripheral insulin levels 
7-8 times basal as compared to the two-fold increment in response 
to protein. Insulin levels could not be measured in the diabetics, 
n 
but we can presume that they are reduced in comparison to normals." 
Infusion of physiological Increments of insulin into the forearm 
stimulates uptake of amino acids into muscle, with uptake of iso- 
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leucine and leucine predominating, ‘ Numerous reports have con¬ 
firmed the effectiveness of endogenous or exogenous insulin in 
i , • • ,, r , . 46,47,69 _ 
lowering tne ammo acid content of plasma in humans. It 
stimulates protein synthesis,^ the transport of amino acids 
71 5 
into cells and the inhibition of protein catabolism. Muscle 
72 73 
is implicated as the primary site of these actions of insulin ^’ . 
A finding of prime importance in this experiment was the effect 
of oral glucose in magnifying the abnormal elevation of plasma 
branched chain amino acids seen in diabetics after protein in¬ 
gestion as compared with normals. Although the glucose blunted 
the rise of these amino acids in both diabetics and normals, the 
diabetics were probably unable to respond as well as normals with 
an adequate insulin output to take care of the additional glucose 
load. The magnified difference in insulin levels between diabetics 
and normals is reponsible for further impairing uptake of amino 
acids by muscle in the diabetics, resulting in the abnormally 
elevated levels seen in venous plasma. In this experiment, leucine 
and isoleucine showed greater abnormal elevations in diabetics 
than valine, and this agrees with previous data showing insulin to 
have a greater effect on uptake of leucine and isoleucine than 
12 
valine by muscle. By exaggerating the metabolic consequences on 
insulin lack, glucose ingestion increases protein intolerance in 
diabetics. 
The fall in alanine levels after the addition of glucose to a 
protein meal is more complicated to explain. Following the stimula¬ 




either a rise or a lack of change in alanine levels are seen in 
42 
normal man. This is thought to be caused by an hepatic effect 
of insulin in shutting off glucoaeogenesis, thereby inhibiting 
alanine uptake as a gluconeogenic precursor and causing alanine to 
& 
build up in the systemic circulation. After protein ingestion, 
a transient but significant lowering of leg alanine output was 
33 
observed in normal subjects but not in diabetics. Since insulin 
reduces the level of protein catabolism in muscle, it reduces the 
0-n 
availability of free amino acids as,alpha amino nitrogen source 
for alanine production by transamination of pyruvate. However, 
at the same time( it stimulates pyruvate formation*, thus the net 
effect of insulin on forearm muscle may be no change in net 
alanine balance. The present findings suggest that the Drotein 
anabolic effects of insulin are further accentuated when glucose 
is added to the mea.l7 thereby reducing alanine outflow from muscle. 
The protein-sparing effect of the mild ketosis that occurs in 
diabetics may account for the lower alanine levels in the diabetics 
relative to normals. In addition, the diabetics have ongoing hepatic 
glucose production and hperglucagonernia after protein ingestion, 
which may involve increased alanine utilization as a gluconeogenic 
precursor. The addition of glucose to a protein meal in diabetes 
does not appear to raise glucagon levels, but it may raise the 
insulin response enough to reduce hepatic glucoaeogenesis and 
uptake of alanine. Therefore, alanine levels in diabetics probably 
reflect the balancing of the protein sparing effects of ketosis with 
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the residual ability, of insufficient output of insulin to affect 
both uptake of alanine in the liver and release from peripheral muscle. 
One might argue that the lower amino acid levels seen after 
glucose plus protein ingestion might be due to some type of 
inhibitory effect of glucose on amino acid absorption in the gut. 
Experiments on the effect of hexoses on amino acid transport in 
intestine show that galactose inhibits amino acid transport, but 
the effects of glucose are very variable. Some investigators have 
shown that glucose enhances amino acid transport into mucosal cells 
of everted sacs of rat ileum and counteracts the inhibitory effect 
14 15 
of galactose. * Others have found glucose to have no 
effect on amino acid transport in some situations,^ and a mild 
inhibitory effect on alanine, glycine, and valine in other condi- 
77 
tions. Similar experiments with valine and leucine in rat 
intestine^’' ^ and alanine in guinea pig intestine^ failed to 
demonstrate any direct effect of glucose on amino acid transport. 
Experiments of amino acid uptake in intestinal rings suggest an 
81 
inhibitory effect of glucose. Since these experiments exhibit 
variable results in a wide variety of experimental conditions, it is 
difficult ?;o compare them to the in vivo situation of ingestion in 
humans. In addition, since glucose appears to blunt the rise in 
some amino acids more effectively in normals than in diabetics, anyone 
postulating that glucose inhibits protein absorption would have to 
explain why this does not occur to the same extent in diabetes. 
There is no^data to refute a possible role of oral glucose in 
inhibition of amino acid absorption, and it cannot be ruled out 
from consideration in this study. 
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It is important to note that in this experiment, the addition 
of a large protein meal to a standard glucose tolerance test did not 
cause any significant rise in the insulin levels above the normal 
Insulin response to a glucose tolerance test. Studies of intravenous 
infusions in man have shown that a number of individual amino acids 
82 
are insulin secretagogues, and that there is an added, synergistic 
83 
effect of certain pairs of amino acids and combinations of amino 
84 
acids and glucose on insulin secretion. When a given quantity 
of glucose is administered by the ora] route5 however, it promotes 
an even greater secretion of insulin in normal man than the same 
43 
quantity of insulin administered intravenously. This effect 
has been attributed to the added stimulation of insulin by gastric 
inhibitory peptide and the possible extra-pancreatic action of other 
85 
humoral secretions. In comparison, triglyceride absorption 
86 
from the gut is associated with little or no insulin secretion. 
Since this experiment presents quantities of protein and car¬ 
bohydrate that are not inconsistent with those found in a large 
ordinary meal, it illustrates the primacy of carbohydrate rather 
than protein in influencing insulin secretion in the normal physiologi¬ 
cal state. A large quantity of protein has little or no effect 
upon either the insulin response to an oral glucose load or the 
resulting glucose tolerance, while that same quantity of glucose 




SUMMARY AND CONCLUSIONS 
Diabetic and normal subjects were studied to determine the. 
effect of an oral glucose load on the response of amino acids, 
hormones and glucose to a protein meal. In normals, the addition 
of glucose to a protein meal enhances the insulin response to pro¬ 
tein, but does not. significantly raise either insulin levels or 
blood glucose more than ingestion of the glucose alone. Whereas 
ingestion of protein alone causes a glucagon rise in both normal 
subjects and diabetics, glucose plus protein ingestion causes a 
fall in glucagon levels of normals without affecting the glucagon 
rise seen in diabetics after a protein meal. There is a hyper¬ 
glycemic response to pure protein ingestion in diabetes. 
The addition of glucose to oral protein markedly blunts the 
rise in branched chain amino acids in both normals and diabetics, 
while promoting an earlier and more consistent accentuation of the 
elevation of these amino acids in the diabetics relative to normals. 
Each branched chain amino acid resembles the other in its response 
in plasma to protein and glucose-protein ingestion, suggesting a common 
hormonal impact on all three amino acids. The addition of glucose 
to a protein meal also appears to have a greater effect in blunting 
the postprandial rise of alanine and several other amino acids in 
normals than it does in diabetics. 
The data from this experiment suggests that diabetics have a 
defect in protein tolerance relative to normals which is enhanced 
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by the addition of glucose to a protein meal. Diabetics are unable 
t.o respond to the increased glucose load with an insulin output that 
is comparable to normals, and this results in diminished uptake and 
utilization of branched chain amino acids for nitrogen repletion 
ir. peripheral muscle. The results underscore the role of insulin 
in nitrogen repletion in normal man and suggest a possible mechanism 
for the protein wasting often seen in diabetes. Insulin lack and 
inappropriate hyperglucagonemia in diabetics result in an abnormal 
elevation in blood glucose and lowering of plasma alanine in re¬ 
sponse to protein ingestion. This is probably caused by ongoing 
hepatic gluconeogenesis and uptake of alanine by the liver as a 
glucose pi&rcursor. 
This experiment examines the interrelationship of protein and 
carbohydrate as hormonal secretogogues in normal man. It illustrates 
the particular importance of glucose rather than protein from the 
normal diet stimulating insulin secretion, while providing addi¬ 
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